Lung cancer risk score for ever and never smokers in China

被引:8
|
作者
Ma, Zhimin [1 ,2 ,3 ]
Lv, Jun [4 ,5 ]
Zhu, Meng [1 ,2 ]
Yu, Canqing [4 ]
Ma, Hongxia [1 ,2 ]
Jin, Guangfu [1 ,2 ]
Guo, Yu [6 ]
Bian, Zheng [6 ]
Yang, Ling [7 ,8 ]
Chen, Yiping [7 ,8 ]
Chen, Zhengming [7 ,8 ]
Hu, Zhibin [1 ,2 ]
Li, Liming [7 ,8 ,11 ]
Shen, Hongbing [1 ,2 ,9 ,10 ]
机构
[1] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatmen, Nanjing, Jiangsu, Peoples R China
[3] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China
[4] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China
[5] Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Beijing, Peoples R China
[7] Univ Oxford, Clin Trial Serv Unit, Oxford, Oxfordshire, England
[8] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, Oxfordshire, England
[9] Chinese Acad Med Sci, Res Units Cohort Study Cardiovasc Dis & Canc, Beijing, Peoples R China
[10] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China
[11] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
early-onset cancer; lung cancer screening; lung cancer; never smokers; prediction model; DOSE-RESPONSE RELATIONSHIP; THAN; 50; YEARS; PREDICTION MODEL; CIGARETTE-SMOKING; VALIDATION; SELECTION; BIOBANK; MARKERS;
D O I
10.1002/cac2.12463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMost lung cancer risk prediction models were developed in European and North-American cohorts of smokers aged & GE; 55 years, while less is known about risk profiles in Asia, especially for never smokers or individuals aged < 50 years. Hence, we aimed to develop and validate a lung cancer risk estimate tool for ever and never smokers across a wide age range. MethodsBased on the China Kadoorie Biobank cohort, we first systematically selected the predictors and explored the nonlinear association of predictors with lung cancer risk using restricted cubic splines. Then, we separately developed risk prediction models to construct a lung cancer risk score (LCRS) in 159,715 ever smokers and 336,526 never smokers. The LCRS was further validated in an independent cohort over a median follow-up of 13.6 years, consisting of 14,153 never smokers and 5,890 ever smokers. ResultsA total of 13 and 9 routinely available predictors were identified for ever and never smokers, respectively. Of these predictors, cigarettes per day and quit years showed nonlinear associations with lung cancer risk (Pnon-linear < 0.001). The curve of lung cancer incidence increased rapidly above 20 cigarettes per day and then was relatively flat until approximately 30 cigarettes per day. We also observed that lung cancer risk declined sharply within the first 5 years of quitting, and then continued to decrease but at a slower rate in the subsequent years. The 6-year area under the receiver operating curve for the ever and never smokers' models were respectively 0.778 and 0.733 in the derivation cohort, and 0.774 and 0.759 in the validation cohort. In the validation cohort, the 10-year cumulative incidence of lung cancer was 0.39% and 2.57% for ever smokers with low (< 166.2) and intermediate-high LCRS (& GE; 166.2), respectively. Never smokers with a high LCRS (& GE; 21.2) had a higher 10-year cumulative incidence rate than those with a low LCRS (< 21.2; 1.05% vs. 0.22%). An online risk evaluation tool (LCKEY; ) was developed to facilitate the use of LCRS. ConclusionsThe LCRS can be an effective risk assessment tool designed for ever and never smokers aged 30 to 80 years.
引用
收藏
页码:877 / 895
页数:19
相关论文
共 50 条
  • [31] Is lung cancer in never smokers still an unknown disease?
    Candal-Pedreira, Cristina
    Ruano-Ravina, Alberto
    Perez-Rios, Monica
    TRANSLATIONAL CANCER RESEARCH, 2022,
  • [32] Clinical Characteristics and Survival in Never Smokers With Lung Cancer
    Parente Lamelas, Isaura
    Abal Arca, Jose
    Blanco Cid, Nagore
    Alves Perez, Maria Teresa
    Dacal Quintas, Raquel
    Gomez Marquez, Hugo
    Garcia Montenegro, Rogelio Alejandro
    Marcos Velazquez, Pedro
    ARCHIVOS DE BRONCONEUMOLOGIA, 2014, 50 (02): : 62 - 66
  • [33] Tracing Lung Cancer Risk Factors Through Mutational Signatures in Never-Smokers
    Landi, Maria Teresa
    Synnott, Naoise C.
    Rosenbaum, Jennifer
    Zhang, Tongwu
    Zhu, Bin
    Shi, Jianxin
    Zhao, Wei
    Kebede, Michael
    Sang, Jian
    Choi, Jiyeon
    Mendoza, Laura
    Pacheco, Marwil
    Hicks, Belynda
    Caporaso, Neil E.
    Abubakar, Mustapha
    Gordenin, Dmitry A.
    Wedge, David C.
    Alexandrov, Ludmil B.
    Rothman, Nathaniel
    Lan, Qing
    Garcia-Closas, Montserrat
    Chanock, Stephen J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2021, 190 (06) : 962 - 976
  • [34] Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
    Samet, Jonathan M.
    Avila-Tang, Erika
    Boffetta, Paolo
    Hannan, Lindsay M.
    Olivo-Marston, Susan
    Thun, Michael J.
    Rudin, Charles M.
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5626 - 5645
  • [35] Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers
    Malhotra, Jyoti
    Waterboer, Tim
    Pawlita, Michael
    Michel, Angelika
    Cai, Qiuyin
    Zheng, Wei
    Gao, Yu-Tang
    Lan, Qing
    Rothman, Nathaniel
    Langseth, Hilde
    Grimsrud, Tom K.
    Yuan, Jian-Min
    Koh, Woon-Puay
    Wang, Renwei
    Arslan, Alan A.
    Zeleniuch-Jacquotte, Anne
    Boffetta, Paolo
    BRITISH JOURNAL OF CANCER, 2016, 115 (09) : 1131 - 1139
  • [36] The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
    Andrzejczak, Anna
    Partyka, Anna
    Wisniewski, Andrzej
    Porebska, Irena
    Pawelczyk, Konrad
    Ptaszkowski, Kuba
    Kusnierczyk, Piotr
    Jasek, Monika
    Karabon, Lidia
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [37] Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers
    Jyoti Malhotra
    Tim Waterboer
    Michael Pawlita
    Angelika Michel
    Qiuyin Cai
    Wei Zheng
    Yu-Tang Gao
    Qing Lan
    Nathaniel Rothman
    Hilde Langseth
    Tom K Grimsrud
    Jian-Min Yuan
    Woon-Puay Koh
    Renwei Wang
    Alan A Arslan
    Anne Zeleniuch-Jacquotte
    Paolo Boffetta
    British Journal of Cancer, 2016, 115 : 1131 - 1139
  • [38] Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China
    Guo, Lan-Wei
    Lyu, Zhang-Yan
    Meng, Qing-Cheng
    Zheng, Li-Yang
    Chen, Qiong
    Liu, Yin
    Xu, Hui-Fang
    Kang, Rui-Hua
    Zhang, Lu-Yao
    Cao, Xiao-Qin
    Liu, Shu-Zheng
    Sun, Xi-Bin
    Zhang, Jian-Gong
    Zhang, Shao-Kai
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [39] Lung Cancer in Never-Smokers: A Multicenter Case-Control Study in North China
    Liang, Di
    Wang, Jingxi
    Li, Daojuan
    Shi, Jin
    Jing, Jin
    Shan, Baoen
    He, Yutong
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [40] Incidence trends and risk factors of lung cancer in never smokers: Pooled analyses of seven cohorts
    Rissanen, Emilia
    Heikkinen, Sanna
    Seppa, Karri
    Ryynanen, Heidi
    Eriksson, Johan G.
    Harkanen, Tommi
    Jousilahti, Pekka
    Knekt, Paul
    Koskinen, Seppo
    Mannisto, Satu
    Rahkonen, Ossi
    Rissanen, Harri
    Malila, Nea
    Laaksonen, Maarit A.
    Pitkaniemi, Janne
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (12) : 2010 - 2019